Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics
- PMID: 6124583
- PMCID: PMC6564386
- DOI: 10.1523/JNEUROSCI.02-07-00895.1982
Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics
Abstract
In order to develop more selective methods for labeling brain dopamine receptors, this study describes in detail the properties of 2-amino-6,7,-[3H]dihydroxy-1,2,3,4,-tetrahydronaphthalene ([3H] ADTN) binding to dopaminergic sites in rat, calf, and human brain. [3H]ADTN labeled two distinct types of dopaminergic binding sites in the brain striatum of the rat, calf, and human. Very low concentrations of dopamine and dopaminergic catecholamines (with IC50 values of 1 to 10 nM) inhibited the binding of [3H]ADTN to both sites. Neuroleptics, however, inhibited the binding of [3H]ADTN in two distinctly separate concentration ranges, with IC50 values of 0.15 to 40 nM at one site and 100 and 50,000 nM at the other site. The site with high affinity for dopamine and low affinity for neuroleptics had binding properties that corresponded to those of the previously characterized D3 site (List, S., M. Titeler, and P. Seeman (1980) Biochem. Pharmacol. 29: 1621-1622). The [3H]ADTN binding site with high affinity for neuroleptics demonstrated binding characteristics similar to a site labeled by 3H-Neuroleptics (Sokoloff, P., M. P. Martres, and J. C. Schwartz (1980) Naunyn Schmiedebergs Arch. Pharmacol. 315: 89-102). [3H]Apomorphine appeared to label the same two sites as [3H]ADTN, while [3H]dopamine labeled only the D3 site. Scatchard analysis of [3H]ADTN or [3H]apomorphine binding, under conditions for selective labeling of the low affinity neuroleptic site (D3) and the high affinity site for neuroleptics, detected a density of 70 fmol/mg of protein for each. The density of the D3 site in the calf striatum (170 fmol/mg of protein) was much greater than that of the high affinity neuroleptic site (50 fmol/mg). In the rat, the dissociation constant (KD) of [3H]ADTN was 2 nM for both sites. [3H]Apomorphine, however, had a higher affinity for the D3 site (KD=1.6 nM) than for the high affinity neuroleptic site (KD=4.2 nM). The present results may explain previously observed species and laboratory differences between the binding of [3H]ADTN, [3H]apomorphine, and [3H]dopamine.
Similar articles
-
[3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.J Neurochem. 1982 Nov;39(5):1363-73. doi: 10.1111/j.1471-4159.1982.tb12579.x. J Neurochem. 1982. PMID: 7119802
-
Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.Eur J Pharmacol. 1979 Apr 15;55(2):137-42. doi: 10.1016/0014-2999(79)90385-6. Eur J Pharmacol. 1979. PMID: 456412
-
Properties of dopamine agonist and antagonist binding sites in mammalian retina.Brain Res. 1980 Aug 4;194(2):403-18. doi: 10.1016/0006-8993(80)91221-4. Brain Res. 1980. PMID: 6770965
-
Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.J Neurochem. 1986 Apr;46(4):1058-67. doi: 10.1111/j.1471-4159.1986.tb00618.x. J Neurochem. 1986. PMID: 2936868
-
Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.Biochem Pharmacol. 1983 Oct 1;32(19):2873-80. doi: 10.1016/0006-2952(83)90391-x. Biochem Pharmacol. 1983. PMID: 6626260
Cited by
-
A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.CNS Neurosci Ther. 2008 Fall;14(3):248-62. doi: 10.1111/j.1755-5949.2008.00047.x. CNS Neurosci Ther. 2008. PMID: 18801115 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources